Fumarate hydratase-deficient renal cell carcinoma: A clinicopathological study of seven cases including hereditary and sporadic forms-Reference-Cited by-同舟云学术

Fumarate hydratase-deficient renal cell carcinoma: A clinicopathological study of seven cases including hereditary and sporadic forms

Published:2020-12 Issue: Volume:49 Page:151599
ISSN:1092-9134
Container-title:Annals of Diagnostic Pathology
language:en
Short-container-title:Annals of Diagnostic Pathology

Author:

Kuroda Naoto,Tsutsui Miho,Iguchi Mitsuko,Nobuoka Emi,Uehara Takeshi,Sonobe Yuta,Morinaga Yukiko,Shibuya Shinsuke,Oda Wakako,Yanai Hiroyuki,Kawada Chiaki,Karashima Takashi,Yamasaki Ichiro,Inoue Keiji,Nagashima Yoji

Publisher

Elsevier BV

Subject

General Medicine,Pathology and Forensic Medicine

Reference20 articles.

1. Inherited susceptibility to uterine leiomyomas and renal cell cancer;Launonen;Proc. Natl. Acad. Sci. U. S. A.,2001

2. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer;Tomlinson;Nat. Genet.,2002

3. Mutation in the fumarate hydratase gene case hereditary leiomyomatosis and renal cell cancer in families in North America;Toro;Am. J. Hum. Genet.,2003

4. Fumarate hydratase-deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndrome;Trpkov;Am. J. Surg. Pathol.,2016

5. The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome;Merino;Am. J. Surg. Pathol.,2007

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Primary and Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinomas Documents Morphologic Divergence and Potential Diagnostic Pitfall With Peritoneal Mesothelioma;Modern Pathology;2024-09

2. Fumarate Hydratase-Deficient Renal Cell Carcinoma—A Clinicopathological Study of a Series of 11 Cases;Indian Journal of Medical and Paediatric Oncology;2024-05-07

3. The clinicopathologic and molecular features, and treatment outcome of fumarate hydratase-deficient renal cell carcinoma: a retrospective comparison with type 2 papillary renal cell carcinoma;Aging;2024-02-19

4. Unmasking the enigma: A case of Fumarate Hydratase-deficient renal cell carcinoma;International Journal of Surgery Case Reports;2023-12

5. Genomic alterations and diagnosis of renal cancer;Virchows Archiv;2023-11-24